
Urgo and its French public- and private-sector partners announced on November 20 that they had made artificial skin in a laboratory for people with severe burns, BFMTV reported. The material is designed to be grafted, but clinical trials still need to test whether it can safely close wounds without taking healthy skin from the patient. The developers hope to bring it to market around 2040; that is a commercial ambition, not a date when hospitals can expect to offer it.
For someone with severe burns, the potential benefit concerns both the wound and the healthy skin that treatment requires. As BFMTV reported, treating severe wounds can involve taking skin from elsewhere on the patient’s body, repeated operations and long hospital stays. The aim of the GENESIS project is to avoid that skin harvest and, in doing so, reduce the pain associated with care.
Calling the skin “ready to graft” describes what the team designed it for in the lab. The clinical milestone for patients will be evidence from trials that the material is safe and can actually close their wounds.
Sources
- BFMTV Actualités · Source date: 2026-11-20
- BFMTV Actualités · Source date: 2026-11-20
Independent editorial content. WUA is not affiliated with any political party. 2026-11-20